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Abstract
Background: The most common tumours of the adrenal gland are adenoma, pheochromocytoma,
adrenocortical carcinoma, and metastases. Although the imaging features of these tumours are
established, the imaging characteristics of uncommon adrenal masses are less well known. In
patients with extradrenal tumour, incidental discovery of an adrenal mass necessitates excluding
the possibility of metastatic malignancy.
Case presentation: A 52 year-old female was diagnosed with oesophageal adenocarcinoma and
treated with oesophagectomy and adjuvant chemotherapy. Sixteen months later on staging CT scan
a 2 × 2 cm adrenal mass was detected, which increased in size over a period of time to 3 × 3 cm
in size. Adrenalectomy was performed and histological examination revealed metastatic
adenocarcinoma within an adrenal adenoma.
Conclusion: The present case highlights the unusual behaviour of an oesophageal adenocarcinoma
causing metastasis to an adrenocortical adenoma.
Background
Due to improvements in radiological diagnosis capabili-
ties, there has been a recent increase in adrenal tumours
that are incidentally discovered in patients who under-
went medical examination by ultrasonography (US),
computed tomography (CT) and magnetic resonance
imaging (MRI), i.e. "adrenal incidentalomas" [1]. In
patients with extra adrenal tumour, incidental discovery
of an adrenal mass necessitates excluding the possibility
of metastatic malignancy [2]. Discrimination between
benign and malignant adrenal mass lesions is a frequent
clinical problem [3]. Important hallmarks used as indica-
tions for surgical intervention are the size, growth rate and
the imaging characteristics of the tumour as well as the
endocrinological behaviour [1]. Here we present an unu-
sual case of metastatic carcinoma within an adrenal ade-
noma.
Case presentation
A 52-year-old woman presented with complaints of dys-
phagia and hoarseness of voice in December 2003. She
was diagnosed to have an advanced moderately differen-
tiated oesophageal adenocarcinoma for which adjuvant
chemotherapy was started. In May 2004, she underwent a
transcervical oesophagectomy and gastric pull up fol-
lowed by postoperative chemotherapy. The postoperative
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interval was uneventful. Staging CT scan performed in
April 2005 revealed a 2 × 2 cm left adrenal mass. Half
body positron emission tomography (PET) scan with 18F-
2-fluoro-D-deoxyglucose (FDG) with CT anatomical
image fusion performed in April 2005 and again in Febru-
ary 2006 revealed an increasing left adrenal mass measur-
ing 3 × 3 cm in size. The left adrenal gland showed an
intense abnormal FDG uptake (Figure 1). This metaboli-
cally active lesion was suggested to represent either a
metastasis or possibly a primary adrenal tumour. FDG
PET scan showed no other foci of metabolically active dis-
ease. The endocrine work-up showed that the adrenal
tumour was hormonally non-functioning. Left adrenalec-
tomy was performed and the specimen was sent for his-
topathological evaluation. Preoperative needle biopsy
was not performed.
The adrenal gland measured 6 × 3.5 × 3.0 cm in size and
weighed 23 grams. On slicing, the adrenal gland con-
tained a mottled spherical lesion measuring 3 cm in diam-
eter (Figure 2A). Histopathological examination revealed
a well circumscribed tumour composed of clear cells
arranged in a nesting pattern, separated by thin fibrovas-
cular stroma. Compressed normal adrenal gland paren-
chyma is seen at the periphery (Figure 2B &3). There was
no evidence of necrosis, mitosis or nuclear pleomor-
phism. The tumour cells stained for Inhibin, Melan A,
Calretinin and Neuron Specific Enolase and are negative
for Chromogranin, Neurofilament and S100 protein. The
features were consistent with an adrenocortical adenoma.
In addition, the adenoma showed multiple deposits of
moderately differentiated adenocarcinoma (Figure 2B
&3). The neoplastic glands stained for AE1/AE3, Cytoker-
atin 7, Cytokeratin 20 and Carcinoembryonic antigen
(CEA). The overall features were consistent with metasta-
sis of moderately differentiated adenocarcinoma, from a
known primary in oesophagus, to an adrenocortical ade-
noma.
The follow-up of the patient was uneventful for 6 months
following surgery.
Discussion
Adrenal mass lesions may represent a variety of patho-
logic entities, including benign and malignant primary
tumours of the adrenal cortex of medulla, secondary
malignancies metastatic to the adrenal gland, and other
benign conditions such as haemorrhage, granulomatous
inflammation and simple cysts. Of these possibilities, the
adenomas and metastases make up most of the adrenal
mass lesions in the adult population [3]. The adrenal
glands are susceptible organs for metastases from various
malignancies of which the largest proportion represent
spread from lung or breast primaries. Other sites from
Low power magnification showing an adenoma composed of  clear cells arranged in a nesting pattern with metastatic aden- ocarcinoma Figure 3
Low power magnification showing an adenoma composed of 
clear cells arranged in a nesting pattern with metastatic aden-
ocarcinoma. (Haematoxylin and Eosin stain X100)
A). CT scan image Figure 1
A). CT scan image and B). 18FDG-PET scan.18FDG-PET scan 
with CT anatomical image fusion (axial view) shows an 
intense abnormal FDG uptake within the adrenal gland sug-
gestive of metastasis or possibly a primary tumour.
A)-Photograph of the gross specimen of the enlarged adrenal  gland showing a mottled spherical lesion measuring 3 cm in  diameter, with compressed normal adrenal gland at the  periphery Figure 2
A)-Photograph of the gross specimen of the enlarged adrenal 
gland showing a mottled spherical lesion measuring 3 cm in 
diameter, with compressed normal adrenal gland at the 
periphery. B)-Scanner view showing the well-circumscribed 
adenoma with foci of metastatic adenocarcinoma. (Haema-
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which adrenal metastases may develop include kidney
and ovary and the adrenal may be the site for metastatic
melanoma and involvement by lymphoma or leukaemia
[1]. An analysis of the tumour registry data (1994–1996)
at M.D. Anderson Cancer Centre, revealed that adrenal
metastasis occurred in 202 cases out of 4399 cases, with
lung and kidney being the primary organs of origin in
51% and 28% of cases respectively. Adrenal metastasis of
oesophageal adenocarcinoma was seen in 3% of cases [4].
In a review of autopsy cases, the adrenal glands were
involved in 27% of cancer cases and the incidence of adre-
nal metastases in patients with breast and lung cancer was
approximately 39 and 35%, respectively. Among patients
with cancer, more than 50% of clinically unapparent adre-
nal masses are reported as metastases [1]. In the present
case, the adrenal mass was removed considering it to be
metastatic and the adenomatous component was detected
only after pathological examination.
Radiologically, MRI is known to be effective in distin-
guishing between benign and malignant lesions. Metas-
tases are usually hypointense on T1-weighted images but
hyperintense on T2-weighted images. In particular,
benign adenomas exhibit clear suppression of the signals
on chemical-shift imaging. [1,2]. Unfortunately, chemi-
cal-shift MRI was not performed at the initial examination
in our present case. Available data regarding the size sug-
gest that lesions smaller than 4 cm are generally benign
[5]. But this was not so in our case as the adrenal mass was
3 cm in size. This case demonstrates the advantages of
FDG-PET in characterizing adrenal masses in patients
with clinically unapparent adrenal masses or cancer work-
up including differentiation of malignant from benign
adrenal masses. The adrenal glands are not discretely
identified on a normal PET scan. However, they are often
visible on PET/CT studies with minimal uptake. Focal
adrenal uptake is abnormal. But, besides metastatic dis-
ease, other causes of focal adrenal uptake include benign
and malignant pheochromocytoma, giant adrenal mye-
lolipoma and adrenal carcinoma. These can be differenti-
ated from metastasis by CT or MRI. Although bilateral
uptake is worrisome for metastasis, this can also be sec-
ondary to adrenal hyperplasia. This should be considered
when the bilateral uptake is nodular. Hence it is impor-
tant to recognize that not all lesions in cancer patients are
metastasis [6,7]. The sensitivity and specificity of PET in
characterizing adrenal lesions in patients with known
malignancy is 100% and 94% respectively. The sensitivity
of PET is equal to MRI and superior to CT [6].
Conclusion
Adrenal gland is a common site of metastasis from various
tumours especially of lung or breast, and radiologically
the sensitivity of PET in detecting them is equal to MRI
and superior to CT. The present case also highlights the
unusual behaviour of an oesophageal adenocarcinoma
causing metastasis to an adrenocortical adenoma.
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